Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Endocrine-Related Cancer|April 28, 2018
Cellular kinetics of MED12-mutant uterine leiomyoma growth and regression in vivoVanida A Serna, Xin Wu, Wenan Qiang, et al.Cancer Research|October 22, 2017
Subtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine LeiomyomaXin Wu, Vanida A Serna, Justin Thomas, et al.Molecular Endocrinology (Baltimore, Md.)|May 11, 2016
FGFR2IIIb-MAPK Activity Is Required for Epithelial Cell Fate Decision in the Lower Müllerian DuctJumpei Terakawa, Altea Rocchi, Vanida A Serna, et al.Cell Death and Differentiation|June 24, 2020
SIX1 cooperates with RUNX1 and SMAD4 in cell fate commitment of Müllerian duct epitheliumJumpei Terakawa, Vanida A Serna, Devi M Nair, et al.Cell Death and Differentiation|July 11, 2018
Transient inhibition of p53 homologs protects ovarian function from two distinct apoptotic pathways triggered by anticancer therapiesSo-Youn Kim, Devi M Nair, Megan Romero, et al.Human Reproduction (Oxford, England)|May 1, 2016
Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft modelFaezeh Koohestani, Wenan Qiang, Amy L MacNeill, et al.Oncotarget|October 6, 2017
Novel SOX17 frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutationsChristopher J Walker, Matthew J O'Hern, Vanida A Serna, et al.Developmental Biology|July 9, 2013
Diethylstilbestrol induces vaginal adenosis by disrupting SMAD/RUNX1-mediated cell fate decision in the Müllerian duct epitheliumMonica M Laronda, Kenji Unno, Kazutomo Ishi, et al.Biorxiv : the Preprint Server for Biology|April 28, 2025
Cell type-specific enhancers regulate IL-22 expression in innate and adaptive lymphoid cellsAnkita Saini, Leone S Hopkins, Vanida A Serna, et al.Nature Communications|March 15, 2026
Cell type-specific enhancers regulate IL-22 expression in innate and adaptive type 3 lymphoid cellsAnkita Saini, Leone S Hopkins, Vanida A Serna, et al.Pageof 2